📈 ETFWinnerResearch & Rankings
NVO

NVO

Novo Nordisk A/S · NYSE

$46.26
↘ -0.93 (-1.97%)
Previous close
$47.19
Day range
45.70 – 46.33
52-week range
35.12 – 64.16
Volume
12,975,792
Held by
5 ETFs
Max weight
35.50%

The price sits 38.4% of the way up its 52-week range.

Price is the close for 27 Aug 2026, sourced from Yahoo Finance and checked against the 52-week range before publishing. Delayed and for research only — not investment advice.

Price chart

Which ETFs hold NVO?

Novo Nordisk appears in 5 of the funds we track, with its heaviest allocation at 35.50% in EDEN.

ETFFundWeightCategoryMarket
EDEN iShares MSCI Denmark ETF 35.50% Country/Region 🇩🇰 Denmark
VGK Vanguard FTSE Europe ETF 3.80% International Europe
EFA iShares MSCI EAFE ETF 2.50% International 🇺🇸 United States
IEFA iShares Core MSCI EAFE ETF 2.20% International International
VXUS Vanguard Total International Stock ETF 1.80% International Global ex-US

What this means for your portfolio

If you hold more than one of the funds listed above, your exposure to Novo Nordisk is the sum of its weight in each — not the weight shown on any single fund page. This is how investors end up far more concentrated in a handful of companies than they intended, particularly when a broad market fund and a sector or thematic fund are held side by side.

Across the 5 funds holding it, the average published weight is 9.16%.

Other healthcare holdings

Community

NVO discussion

Questions on fair value, cost, dividends and risk — answered with the fund data on this page.

Ask a question about NVO

Questions are reviewed before publishing. Please do not ask for personal investment advice — we cannot provide it.